Monday, February 8, 2016

NIH- National Heart, Lung and Blood Institute - Phase II and phase III randomized clinical trials

The purpose of this grant is to fund investigator-initiated multi-site randomized controlled clinical trials. The trials may address any research question related to the mission and goals of the NHLBI and may test clinical or behavioral interventions. The grant is appropriate for studies to conduct phase II and phase III randomized clinical trials where participants are recruited from multiple sites.

Examples of diseases covered NHLBI - 
Anaemia
Bronchitis 
Diabetic Heart Disease
Metabolic Syndrome

Deadline - June 5th 2016

More details - http://grants.nih.gov/grants/guide/pa-files/PAR-13-128.html

Foreign Institutions are eligible to apply